LINCOLN PHARMACEUTICALS
Back to Income Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹46.58 | ₹36.40 | ₹34.63 | ₹31.08 | ₹25.72 |
What is the latest Earnings Per Share (EPS) of LINCOLN PHARMACEUTICALS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹46.58 |
| Mar2024 | ₹36.40 |
| Mar2023 | ₹34.63 |
| Mar2022 | ₹31.08 |
| Mar2021 | ₹25.72 |
How is Earnings Per Share (EPS) of LINCOLN PHARMACEUTICALS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹46.58 | 27.97 | |
| Mar2024 | ₹36.40 | 5.11 | |
| Mar2023 | ₹34.63 | 11.42 | |
| Mar2022 | ₹31.08 | 20.84 | |
| Mar2021 | ₹25.72 | - | |
Compare Earnings Per Share (EPS) of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,158.2 Cr | -0.2% | -7.4% | 4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,993.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | -0.2% |
-7.4% |
4% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses